US 11286290
Anti-VEGF protein compositions and methods for producing the same
granted A61KA61K38/179A61K38/1866
Quick answer
US patent 11286290 (Anti-VEGF protein compositions and methods for producing the same) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K38/179, A61K38/1866, A61P, A61P17/06